Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis
Author:
Affiliation:
1. Merck & Co., Inc.; Kenilworth NJ USA
2. F.C.E. ARENSIA Exploratory Medicine LLC; Chisinau Republic of Moldova
3. ARENSIA Exploratory Medicine LLC; Tbilisi Georgia
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13670/fullpdf
Reference45 articles.
1. Psoriasis comorbidities;Gottlieb;J Dermatolog Treat,2008
2. Mechanisms of monoclonal antibody-drug interactions;Zhou;Annu Rev Pharmacol Toxicol,2011
3. Risk-based strategy for the assessment of pharmacokinetic drug-drug interactions for therapeutic monoclonal antibodies;Zhou;Drug Discov Today,2009
4. Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis;Schmitt;Clin Pharmacol Ther,2011
5. Regulation of drug-metabolizing enzymes and transporters in inflammation;Aitken;Annu Rev Pharmacol Toxicol,2006
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tildrakizumab in Psoriasis and Beyond;Journal of Dermatology and Dermatologic Surgery;2024-01
2. Assessment of the drug–drug interaction potential for therapeutic proteins with pro‐inflammatory activities;Clinical and Translational Science;2023-04-23
3. Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition;Journal of Pharmacy & Pharmaceutical Sciences;2023-02-06
4. Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development;Clinical Pharmacology & Therapeutics;2023-01-17
5. Denosumab: dosing and drug interaction challenges on the path to approval;Overcoming Obstacles in Drug Discovery and Development;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3